Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF) |
Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF) | Phase3 | South Korea | NCT07357727 |
A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction |
Heart Failure With Reduced Ejection Fraction | Phase1 | United States | NCT07465653 |
Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction |
Plaque, Atherosclerotic | Phase4 | China | NCT06372925 |
A Non-Interventional Study PASS to Characterize Secondary Malignancies of Tcell Origin Following Tisagenlecleucel Therapy |
Secondary Malignancies of T-cell Origin | Japan | NCT07378969 | |
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) |
Cardiovascular Disease and Lipoprotein(a) | Phase3 | Argentina Australia Austria Belgium Brazil Bulgaria China Colombia Czechia Denmark France Germany Greece Hong Kong Hungary India Israel Italy Japan Netherlands Poland Portugal Puerto Rico Romania Russia Slovakia South Korea Spain Switzerland Taiwan Turkey (Türkiye) United Kingdom United States View all |
NCT07517263 |
Real-World Treatment Pattern and Clinical Outcome With Influential Factors of HR+/HER2-aBC 1L Patients in China |
HR+/HER2- Advanced or Metastatic Breast Cancer | China | NCT07476170 | |
Impact of Implementation Strategies on Lp(a) Testing in Secondary Care Settings |
Implementing EAS/ESC Guideline Recommendation on Lp(a) Testing in Routine Practice | Germany | NCT07508007 | |
Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China |
Chronic Myeloid Leukemia in Chronic Phase | China | NCT07375355 | |
A Study to Assess the Effects of Zigakibart on IgA Nephropathy. |
Immunoglobulin A Nephropathy (IgAN) | Phase2 | China Japan South Korea Taiwan United States View all |
NCT07146906 |
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia |
Schizophrenia | Phase2 | United States | NCT07467993 |